---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-040926"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2026-09-01T11:30:38+00:00"
generated_at: "2026-09-01T11:35:05.001841+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Indaptus enters $100M ATM offering agreement with H.C. Wainwright

## Summary
- Amended and restated ATM agreement dated Aug 28, 2026, replacing June 2022 agreement with H.C. Wainwright.
- Company may sell up to $100M of common stock through Wainwright as sales agent or principal.
- Placement fee of 3.0% of gross sales price for agent sales; no obligation to sell any shares.
- Prospectus supplement filed Aug 31, 2026 under existing Form S-3 shelf registration (File No. 333-289573).

## SEC filing metadata
- accession: 0001493152-26-040926
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2026-09-01T11:30:38+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315226040926/0001493152-26-040926-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315226040926/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-040926
- JSON: https://secwatch.observer/filing/0001493152-26-040926.json
- Plain text: https://secwatch.observer/filing/0001493152-26-040926.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.